There are three core technologies, services or products developed by i-Ab.

• A computational technology platform was successfully established for high-throughput antibody screening (iHT-AbTM), which incorporates two databases (i-TargetDBTM and i-AbDBTM) as value-added big biomedical data sources. i-Ab provides professional services in contrast with those experiments of conventional platform.

• Screening antibody (i-Ab001, i-Ab002, …) candidates by Preclinical Efficacy and Safety Index (PESI): a perspective analysis of clinical trial

• Computational lead optimization and formulations (i-HitOptTM) for the improvement of pre-clinical tests.